FibroGen, Inc.
FGEN
$6.89
-$0.03-0.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 95.84% | 83.26% | 58.60% | 47.76% | 21.71% |
| Total Depreciation and Amortization | -71.75% | -72.89% | -60.77% | -47.00% | -29.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -69.17% | -69.17% | -59.77% | -63.61% | 0.95% |
| Change in Net Operating Assets | 17.34% | 1.86% | 71.72% | 24.44% | -983.49% |
| Cash from Operations | 72.14% | 56.19% | 63.96% | 36.18% | -14.09% |
| Capital Expenditure | 87.07% | 89.44% | 85.54% | 64.85% | 27.36% |
| Sale of Property, Plant, and Equipment | -- | -- | 42,100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -100.00% | -100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -28.07% | -19.49% | -8.47% | 37.72% | -39.33% |
| Cash from Investing | -26.37% | -18.00% | -6.92% | 39.17% | -39.13% |
| Total Debt Issued | -- | -- | -100.00% | -100.00% | -- |
| Total Debt Repaid | 89.81% | 91.74% | 86.00% | 86.70% | 46.71% |
| Issuance of Common Stock | -99.32% | -99.73% | -99.70% | -99.70% | -42.56% |
| Repurchase of Common Stock | -55.56% | -- | 43.80% | 87.32% | 93.02% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 98.32% | -- | -100.00% | -100.00% | -105.69% |
| Cash from Financing | -100.20% | -100.21% | -100.29% | -100.24% | 12.25% |
| Foreign Exchange rate Adjustments | 173.07% | 122.11% | 196.37% | 159.93% | 56.70% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.56% | 72.60% | 128.79% | 21.76% | -3,220.42% |